Atomoxetine recalls

The FDA has published 18 recalls involving Atomoxetine since 2014. The latest was reported on 27 May 2026. Most were for nitrosamine impurity. Glenmark Pharmaceuticals Inc., USA has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls18since 2014
Last 12 months1reported
Class I00% of total
Ongoing15latest 27 May 2026

Recalls per month, last 24 months

click a bar for that month

Severity split

Class I 0 0%Class II 18 100%Class III 0 0%

Why atomoxetine is recalled

By year

Ongoing atomoxetine recalls

15 active

All atomoxetine recalls, newest first

18 total
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIAtomoxetine Capsules HCL in unit dose foil strip, strips recalledAtomoxetineSafecor HealthLabeling ErrorsTX
DrugCLASS IIAtomoxetine Capsules, USP, 40 mg recalled by Glenmark PharmaceuticalsAtomoxetineGlenmark Pharmaceuticals Inc., USANitrosamine ImpurityNationwide
DrugCLASS IIAtomoxetine Capsules, USP, 10 mg recalled by Glenmark PharmaceuticalsAtomoxetineGlenmark Pharmaceuticals Inc., USANitrosamine ImpurityNationwide
DrugCLASS IIAtomoxetine Capsules, USP, 40 mg recalled by Glenmark PharmaceuticalsAtomoxetineGlenmark Pharmaceuticals Inc., USANitrosamine ImpurityNationwide
DrugCLASS IIAtomoxetine Capsules, USP, 60 mg recalled by Glenmark PharmaceuticalsAtomoxetineGlenmark Pharmaceuticals Inc., USANitrosamine ImpurityNationwide
DrugCLASS IIAtomoxetine Capsules, USP, 100 mg recalled by Glenmark PharmaceuticalsAtomoxetineGlenmark Pharmaceuticals Inc., USANitrosamine ImpurityNationwide
DrugCLASS IIAtomoxetine Capsules, USP, 25 mg recalled by Glenmark PharmaceuticalsAtomoxetineGlenmark Pharmaceuticals Inc., USANitrosamine ImpurityNationwide
DrugCLASS IIAtomoxetine Capsules, USP, 80 mg recalled by Glenmark PharmaceuticalsAtomoxetineGlenmark Pharmaceuticals Inc., USANitrosamine ImpurityNationwide
DrugCLASS IIAtomoxetine Capsules, USP, 18 mg recalled by Glenmark PharmaceuticalsAtomoxetineGlenmark Pharmaceuticals Inc., USANitrosamine ImpurityNationwide
DrugCLASS IIAtomoxetine Capsules, USP, 25 mg recalled by Glenmark PharmaceuticalsAtomoxetineGlenmark Pharmaceuticals Inc., USANitrosamine ImpurityNationwide
DrugCLASS IIAtomoxetine Capsules, USP, 10 mg recalled by Glenmark PharmaceuticalsAtomoxetineGlenmark Pharmaceuticals Inc., USANitrosamine ImpurityNationwide
DrugCLASS IIAtomoxetine Capsules, USP, 100 mg recalled by Glenmark PharmaceuticalsAtomoxetineGlenmark Pharmaceuticals Inc., USANitrosamine ImpurityNationwide
DrugCLASS IIAtomoxetine Capsules, USP, 18 mg recalled by Glenmark PharmaceuticalsAtomoxetineGlenmark Pharmaceuticals Inc., USANitrosamine ImpurityNationwide
DrugCLASS IIAtomoxetine Capsules, USP, 60 mg recalled by Glenmark PharmaceuticalsAtomoxetineGlenmark Pharmaceuticals Inc., USANitrosamine ImpurityNationwide
DrugCLASS IIAtomoxetine Capsules, USP, 80 mg recalled by Glenmark PharmaceuticalsAtomoxetineGlenmark Pharmaceuticals Inc., USANitrosamine ImpurityNationwide
DrugCLASS IIAtomoxetine HCL, Capsule, 80 mg recalled by Aidapak ServicesAidapak ServicesPackaging Defects4 states
DrugCLASS IIAtomoxetine HCL, Capsule, 18 mg recalled by Aidapak ServicesAidapak ServicesPackaging Defects4 states
DrugCLASS IIAtomoxetine HCL, Capsule, 40 mg recalled by Aidapak ServicesAidapak ServicesPackaging Defects4 states

Should you stop taking Atomoxetine?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.